Published in Ann Intern Med on August 01, 1975
Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats. Psychopharmacology (Berl) (2010) 1.03
Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use. Brain Behav (2014) 0.85
Alcohol consumption and hypertension: a review with suggested implications. J Natl Med Assoc (1985) 0.82
A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83
Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict (1989) 6.58
Drug therapy: drug disposition in old age. N Engl J Med (1982) 3.04
The McMaster M.D. program: a case study of renewal in medical education. Acad Med (1989) 2.63
Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr (1988) 2.62
Evidence-based rationing: Dutch pragmatism or government insensitivity? CMAJ (1998) 2.47
Clinical pharmacology and therapeutics of benzodiazepines. Can Med Assoc J (1978) 2.40
Nicotine metabolism defect reduces smoking. Nature (1998) 2.17
A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther (1997) 2.06
Treatment of acetaminophen poisoning. Can Med Assoc J (1981) 2.05
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) Arch Gen Psychiatry (1999) 1.94
Binding of drugs to serum albumin (first of two parts). N Engl J Med (1976) 1.85
Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. Mol Pharmacol (2000) 1.82
Inter- and intrasubject variation in diazepam free fraction. Clin Pharmacol Ther (1979) 1.76
Alcohol intoxication and withdrawal. N Engl J Med (1976) 1.74
Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs. Ann N Y Acad Sci (1971) 1.67
Developing a Canadian prescribing practices network. Network Development Committee of the Canadian Prescribing Practices Network Project. CMAJ (1996) 1.64
The ambiguity of adverse drug reactions. Eur J Clin Pharmacol (1977) 1.64
Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. N Engl J Med (1970) 1.59
Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids. Clin Pharmacol Ther (1970) 1.58
Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol (1981) 1.56
Drug therapy. Binding of drugs to serum albumin (second of two parts). N Engl J Med (1976) 1.49
Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequencies. Clin Pharmacol Ther (1998) 1.44
In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution. Br J Anaesth (1983) 1.39
Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction. Eur J Clin Pharmacol (1983) 1.38
An application of computers to curriculum review and planning. J Med Educ (1986) 1.38
Diazepam actions and plasma concentrations following ethanol ingestion. Eur J Clin Pharmacol (1977) 1.33
Measurement issues in postpartum depression part 1: anxiety as a feature of postpartum depression. Arch Womens Ment Health (2003) 1.30
Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol (1977) 1.28
Variations in drug free fraction during alcohol withdrawal. Br J Clin Pharmacol (1983) 1.28
Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med (1986) 1.27
Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther (1983) 1.26
Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. Drug Metab Dispos (2001) 1.25
Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology (1989) 1.23
Drug kinetics and alcohol ingestion. Clin Pharmacokinet (1979) 1.22
Ranitidine kinetics and dynamics. I. Oral dose studies. Clin Pharmacol Ther (1981) 1.20
Drug therapy: Drugs to decrease alcohol consumption. N Engl J Med (1981) 1.18
Long-term codeine use is associated with depressive symptoms. J Clin Psychopharmacol (1999) 1.18
CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone. Clin Pharmacol Ther (1993) 1.16
Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. Am J Dis Child (1983) 1.15
In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J Pharmacol Exp Ther (1983) 1.14
Paediatric clinical pharmacology and the health of the world's children. Dev Pharmacol Ther (1990) 1.13
Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther (1981) 1.13
Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography. J Chromatogr (1983) 1.10
Influence of age and previous use of diazepam dosage required for endoscopy. Can Med Assoc J (1978) 1.09
Influence of intravenous injection rate on protein binding and vascular activity of diazoxide. Ann N Y Acad Sci (1973) 1.08
Plasma protein binding of diazepam and tolbutamide in chronic alcoholics. J Clin Pharmacol (1976) 1.07
Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos (2001) 1.06
Impact of antibiotic administrative restrictions on trends in antibiotic resistance. Can J Public Health (2006) 1.05
Interactions of amphetamine analogs with human liver CYP2D6. Biochem Pharmacol (1997) 1.05
Pharmacogenetics and ethnoracial differences in smoking. JAMA (1998) 1.05
Age- and gender-related differences in diazepam pharmacokinetics. J Clin Pharmacol (1979) 1.04
Inhibition by fluoxetine of cytochrome P450 2D6 activity. Clin Pharmacol Ther (1993) 1.04
Bendectin: the wrong way to regulate drug availability. Can Med Assoc J (1983) 1.04
Characteristics of dependent and nondependent regular users of codeine. J Clin Psychopharmacol (1999) 1.03
Venlafaxine oxidation in vitro is catalysed by CYP2D6. Br J Clin Pharmacol (1996) 1.03
Ceftazidime disposition in acute and stable cystic fibrosis. Clin Pharmacol Ther (1984) 1.03
NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations. Pharmacogenetics (1998) 1.03
Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique. Clin Pharmacol Ther (1981) 1.02
Update on tamper-resistant drug formulations. Drug Alcohol Depend (2013) 1.01
Chlordiazepoxide and oxazepam disposition in cirrhosis. Clin Pharmacol Ther (1979) 1.00
Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharmacol (1982) 1.00
Acute and chronic drug abuse emergencies in Metropolitan Toronto. Int J Addict (1981) 1.00
An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. Biochem Biophys Res Commun (2002) 0.99
Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability. J Pharmacol Exp Ther (1997) 0.99
Management of the alcohol withdrawal syndrome. Annu Rev Med (1991) 0.99
Liver granulomas and allopurinol. Br Med J (1978) 0.98
Protein binding and vascular activity of diazoxide. N Engl J Med (1969) 0.98
Diurnal variations in plasma diazepam concentrations associated with reciprocal changes in free fraction. Br J Clin Pharmacol (1980) 0.98
Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver. J Pharmacol Exp Ther (2001) 0.97
Importance of protein binding for the interpretation of serum or plasma drug concentrations. J Clin Pharmacol (1982) 0.97
Mood changes during pregnancy and the postpartum period: development of a biopsychosocial model. Acta Psychiatr Scand (2004) 0.96
Intravenous paraldehyde for seizure control in newborn infants. Neurology (1986) 0.96
Hepatic microsomal drug oxidation and electron transport in newborn infants. J Pediatr (1974) 0.96
Cloxacillin absorption and disposition in cystic fibrosis. J Pediatr (1984) 0.96
An improved HPLC method for analysis of methamphetamine and its metabolites in plasma. Eur J Drug Metab Pharmacokinet (1998) 0.96
Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice. J Pharmacol Exp Ther (2006) 0.96
Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics (1997) 0.95
Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone. Br J Clin Pharmacol (1993) 0.95
Sequestration of fentanyl by the cardiopulmonary bypass (CPBP). Eur J Clin Pharmacol (1984) 0.94
Clinical pharmacokinetics of non-opiate abused drugs. Clin Pharmacokinet (1989) 0.94
High-pressure liquid chromatographic analysis of ceftazidime in serum and urine. Antimicrob Agents Chemother (1983) 0.94
Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. CMAJ (2001) 0.94
Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations. Can J Physiol Pharmacol (2001) 0.94
The role of research evidence in pharmaceutical policy making: evidence when necessary but not necessarily evidence. J Eval Clin Pract (1999) 0.94
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. Clin Pharmacol Ther (2008) 0.94
Variability in heparin effect on serum drug binding. Clin Pharmacol Ther (1980) 0.94
Pharmacoepidemiology: a health imperative. J Clin Epidemiol (1991) 0.93
Gender differences in tobacco smoking: higher relative exposure to smoke than nicotine in women. J Womens Health Gend Based Med (2002) 0.93
Characteristics of long-term alprazolam users in the community. J Clin Psychopharmacol (1992) 0.93
Measurement issues in postpartum depression part 2: assessment of somatic symptoms using the Hamilton Rating Scale for Depression. Arch Womens Ment Health (2003) 0.93
Temporal variation in the disposition of theophylline and its metabolites. Clin Pharmacol Ther (1985) 0.91
Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry (2000) 0.91
Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther (1990) 0.91